NCT05377255 Pharmacokinetics (PK) and Safety of Multiple Doses of Intranasal Naloxone in Healthy Adults Status COMPLETED Phase PHASE1
NCT05363501 Pharmacokinetic Evaluation of a New Naloxone Nasal Swab, Naloxone Nasal Spray, and Intramuscular Naloxone Injection in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT05219669 Pharmacokinetic Evaluation of Intranasal Nalmefene Using Three Dosing Regimens Status COMPLETED Phase PHASE1
NCT05123027 Peer Intervention to Link Overdose Survivors to Treatment (PILOT) Status COMPLETED Phase NA
NCT05114460 Vaped Marijuana to Attenuate Naloxone-Precipitated Withdrawal Status TERMINATED Phase PHASE2
NCT05096429 Preventing Overdose Using Information and Data From the Environment Status COMPLETED Phase NA
NCT05093309 Preventing Opioid Overdose Deaths by Empowering Pharmacists to Dispense Naloxone Status COMPLETED Phase NA
NCT05072249 European Cohort Study of the Effectiveness of Take Home Naloxone Status UNKNOWN Phase N/A
NCT04815590 Extended-release Injectable Buprenorphine for Individuals at High Risk of Overdose Status UNKNOWN Phase N/A
NCT04740099 Surviving Opioid Overdose With Naloxone Education and Resuscitation Trial (SOONER) Status WITHDRAWN Phase NA
NCT04713709 A Single-Dose, Bioequivalence Study of FMXIN001 4 mg Microspheres Powder Status COMPLETED Phase PHASE1
NCT04530591 User Acceptability of a Device-Based Opioid Overdose Intervention Status COMPLETED Phase N/A
NCT04317053 Multi-Center Randomized Controlled Trial of Relay- NYC's Nonfatal Overdose Response Program Status COMPLETED Phase NA